Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
59
datasets available to search
ShareScore release 0.9.0
Dataset results
59 results for “18F-FDG PET/CT;”
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT04813705. IPD Sharing: Not stated. Countries: 1. Publications: 0.
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
ClinicalTrials.gov study NCT02717572. IPD Sharing: NO. Countries: 1. Publications: 0.
The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.
ClinicalTrials.gov study NCT06597526. IPD Sharing: NO. Countries: 1. Publications: 0.
Perfusion and Hypoxia Evaluation in Tumors Using 18F-FDG PET/CT
ClinicalTrials.gov study NCT03373994. IPD Sharing: NO. Countries: 1. Publications: 0.
The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study
ClinicalTrials.gov study NCT06747299. IPD Sharing: NO. Countries: 1. Publications: 0.
Bosentan in Myocardium Metabolism and Perfusion Measured by 18F-FDG and 82Rb PET/CT on PAH and CTEPH
ClinicalTrials.gov study NCT02970851. IPD Sharing: NO. Countries: 1. Publications: 0.
The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/CT and Enhanced MRI in Hepatic Malignancies
ClinicalTrials.gov study NCT06700564. IPD Sharing: NO. Countries: 0. Publications: 0.
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT03051568. IPD Sharing: NO. Countries: 1. Publications: 0.
Interest of PET/CT at 18F-FDG in the Post-therapeutic Management of Cervical Cancer
ClinicalTrials.gov study NCT04008095. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer
ClinicalTrials.gov study NCT06232122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
18F-FDG PET/CT to Evaluate pD-1 Monoclonal Antibody With First-line Chemotherapy in Advanced NSCLC
ClinicalTrials.gov study NCT04996927. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL
ClinicalTrials.gov study NCT05113576. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Validation of the Analysis Methodology Behind the Use of Quantitative 18F-FDG PET/CT to Assess Lung Inflammation
ClinicalTrials.gov study NCT03312712. IPD Sharing: NO. Countries: 1. Publications: 0.
To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT
ClinicalTrials.gov study NCT06205888. IPD Sharing: Not stated. Countries: 0. Publications: 0.
18F-FDG PET/CT in the Diagnosis of Tuberculous Pericarditis
ClinicalTrials.gov study NCT05458089. IPD Sharing: NO. Countries: 0. Publications: 0.
Prognostic Value of Pre-therapy 18F-FDG PET/CT for the Outcome of 18 FDG PET-guided SIB-IMRT in Patients With Head and Neck Cancer
ClinicalTrials.gov study NCT06171464. IPD Sharing: Not stated. Countries: 0. Publications: 0.
18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease
ClinicalTrials.gov study NCT04502303. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
18F-FDG PET/CT and Molecular Tumor Characterisation for Staging and Follow-up of Colon Cancer
ClinicalTrials.gov study NCT01636674. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Dataset related to article "18F-FDG PET/CT for response assessment in Hodgkin lymphoma undergoing immunotherapy with checkpoint inhibitors "
<p>This record contains raw data related to article 18F-FDG PET/CT for response assessment in Hodgkin lymphoma undergoing immunotherapy with checkpoint inhibitors</p> <p>Our aim was to evaluate Hodgkin Lymphoma (HL) response to checkpoint inhibitors with <sup>18</sup>F-FDG PET/CT. Forty three refractory or relapsed HL patients were investigated before immunotherapy, 8 weeks and 17 weeks after administration of either nivolumab or pembrolizumab. The median follow-up was 19 months. Best clinical response was complete response (CR) in 26 patients, partial response (PR) in 5 patients, stable disease (SD) in 8 patients, and progression disease (PD) in 4 patients. At the early assessment, Deauville Score (DS) resulted significantly different in responder group compared to nonresponders. SUVmax was significantly lower in responders, while there was no relevant modification in the tumor burden. At interim evaluation, DS well differentiated responder group. A significant decrease in glucose metabolism and tumor burden parameters was observed in responder patients, who presented with a longer progression-free survival then nonresponders. <sup>18</sup>F-FDG PET/CT provides a reliable indication of treatment response under checkpoints inhibitors, even at an early assessment.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.